Curaleaf Holdings (CURLF) Interest & Investment Income (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Interest & Investment Income of $212000.0 in Q1 2026, down 56.65% quarter-over-quarter from $489000.0 in Q3 2025, and up 23.98% on a YoY basis from $171000.0 in Q1 2025.
Curaleaf Holdings (CURLF) Interest & Investment Income (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $212000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 23.98% year-over-year to $212000.0; the TTM figure through Mar 2026 stood at $212000.0 (up 23.98% YoY), while the FY2025 annual figure was $663000.0, down 14.56% from the prior year.
- Interest & Investment Income was $212000.0 for Q1 2026 at Curaleaf Holdings, down from $489000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $601000.0 in Q3 2024 to a low of $17000.0 in Q1 2024.
- Historically, Interest & Investment Income has averaged $215545.5 across 5 years, with a median of $171000.0 in 2025.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income sank 81.15% in 2022, then jumped 2513.04% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $101000.0 in 2022, then plunged by 77.23% to $23000.0 in 2023, then surged by 2513.04% to $601000.0 in 2024, then fell by 18.64% to $489000.0 in 2025, then slumped by 56.65% to $212000.0 in 2026.
- The last three Interest & Investment Income figures came in at $212000.0 (Q1 2026), $489000.0 (Q3 2025), and $338000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | 212,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212,000.00 |
| Sep 30, 2025 | 489,000.00 |
| Jun 30, 2025 | 338,000.00 |
| Mar 31, 2025 | 171,000.00 |
| Sep 30, 2024 | 601,000.00 |
| Jun 30, 2024 | 327,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 69,000.00 |
| Sep 30, 2021 | 495,000.00 |
| Jun 30, 2021 | 366,000.00 |
| Mar 31, 2021 | 88,000.00 |
| Sep 30, 2020 | 6.46 Mn |
| Jun 30, 2020 | 6.42 Mn |
| Mar 31, 2020 | 2.85 Mn |
| Dec 31, 2019 | 9.94 Mn |
| Sep 30, 2019 | 7.49 Mn |